Virus News and Research

Latest Virus News and Research

Even when HIV prevention drug is covered, other costs block treatment

Three years ago, Corey Walsh, who was in a relationship with a man who was HIV-positive, got a prescription for Truvada, a drug approved by the Food and Drug Administration to prevent infection with the virus that causes AIDS.

15 Jul 2019

Reprogramming cells to control HIV infection

Cells from the rare individuals who naturally control HIV infection have been the focus of investigation for nearly 15 years with the aim of elucidating their specific features.

14 Jul 2019

Nanotechnology-based compound used to deliver hepatitis B vaccine

Nanotechnology-based compounds are now being tested as a possible delivery vehicle for vaccines. A team of researchers demonstrated how the oral delivery vehicle SBA-15, one such nanotechnology-based compound can deliver an oral vaccine against hepatitis B to the immune system.

11 Jul 2019

An injection of nanoparticles for spinal cord injuries

Researchers from the University of Michigan used nanopaticles injection to prevent the immune cells of the body from impairing the healing of injured brain and spinal cord. They call this an “EpiPen” or emergency rescue drug for the brain and spinal cord when they suffer trauma.

11 Jul 2019

Scripps CHAVD wins $129 million NIH grant to advance new HIV vaccine approach

The Scripps Consortium for HIV/AIDS Vaccine Development, an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to advance next-generation vaccines designed to coax the immune system into producing antibodies capable of disarming numerous strains of HIV.

11 Jul 2019

EPFL scientists create first world map of regions with highest hepatitis E prevalence

EPFL scientists have created the first world map of regions with the highest prevalence of the hepatitis E virus.

11 Jul 2019

PerkinElmer unveils CE-marked infectious disease immunoassays on EUROIMMUN random access instrument

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and anti-EBV/EBNA (Epstein-Barr Virus) antibodies on its EUROIMMUN RA Analyzer 10 system.

From Revvity 11 Jul 2019

New shingles vaccine reduces outbreaks of painful rash among stem cell transplant patients

A newer form of shingles vaccine reduced outbreaks of the painful rash among patients who were transplanted with their own stem cells, according to a study led by a Duke Health researcher and published today in JAMA.

11 Jul 2019

Puzzling paralysis affecting healthy children warns CDC

The Centers for Disease Control and Prevention (CDC) has warned that a series of rare and difficult to treat cases of paralysis are being seen in otherwise healthy children since 2018. This outbreak is 2018 may soon make a comeback in 2020 the organization warns doctors and paediatricians. The report was published in the CDC’s Vital Signs this week.

11 Jul 2019

British boys to receive HPV jabs

From this September, boys of 12 and 13 will receive the HPV vaccine in all UK schools, hopefully preventing mouth, throat, penile and anal cancers caused by this oncovirus.

10 Jul 2019

UMD researchers connect a protein to antibody immunity for the first time

Human cytomegalovirus may not be a household name as far as viruses go, but according to Xiaoping Zhu, professor and chair in Veterinary Medicine at UMD, half of the population walking around campus is likely to be a carrier.

10 Jul 2019

Common virus exists in over one-third of the countries worldwide

We are all the same, yet we are all different. With the participation of researcher Josefa Antón, from the University of Alicante's Department of Physiology, Genetics and Microbiology, a new study has shown how a family of tiny viruses lives in the guts of humans around the world, yet changes depending on which country we are from.

10 Jul 2019

Virus killing protein could be the real antiviral hero finds study

Researchers have identified a protein that can kill viruses and it forms the missing clue to the natural antiviral mechanism of the body that can target the viruses based on their genetic patterns. This newly identified protein is called KHNYN.

9 Jul 2019

Traveling can also change the makeup of a person's gut

Traveling abroad for the summer can change a person's perspective--and it can also change the makeup of his gut.

9 Jul 2019

Researchers develop new technique to enhance infection-fighting potential of natural chemicals

Researchers in Japan have identified multiple promising new drug candidates to treat antibiotic-resistant infections, including the superbug MRSA (methicillin-resistant Staphylococcus aureus).

8 Jul 2019

Common cold virus strain could be a breakthrough in bladder cancer treatment

Scientists in the UK have found a new way to treat bladder cancer, using a strain of one of the viruses that cause the common cold. The virus is called Coxsackie virus CVA21, and it was found to be oncolytic, or tumor-destroying.

8 Jul 2019

Australia leads the world in childhood immunization coverage

Even as Australia reels under a deadly flu season, some solace may be found in the fact that almost 95% of of five-year-old Australian children are almost completely immunized against deadly childhood diseases, according to the latest report.

8 Jul 2019

Study sheds light on complex caspase-1-induced cell death mechanisms

Most unnecessary or dangerous cells such as virus-infected cells commit suicide by activating an in-built suicide program.

5 Jul 2019

Researchers study the role of nasal ecosystem and viral infection on pneumococcal acquisition

Researchers at LSTM, along with colleagues at the University of Edinburgh and the University Medical Center Utrecht have looked at the impact of the natural microbial flora or microbiota in the nose and viral co-infection on pneumococcal acquisition in healthy adults.

5 Jul 2019

Scientists create powerful method for 'directed evolution' of molecules

UNC School of Medicine scientists created a powerful new "directed evolution" technique for the rapid development of scientific tools and new treatments for many diseases.

5 Jul 2019